Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: An international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial

Anesthesiology

Volumn 109, Issue 2, 2008, Pages 188-197

  Khuenl Brady, Karin S ^g   Pühringer, Friedrich K ^h   Rex, Christopher ^a   Sielenkämper, Andreas W ^b   Claudius, Casper ^c   Larsen, Per Bo ^d   Prins, Martine E ^e   Eikermann, Matthias ^f  

^a Klinikum am Steinenberg   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c Rigshospitalet   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e MERCK RESEARCH LABORATORIES   (United States)

^f UNIVERSITY HOSPITAL ESSEN   (Germany)

^g INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROPOFOL; ROCURONIUM; SUGAMMADEX; ANDROSTANE DERIVATIVE; GAMMA CYCLODEXTRIN DERIVATIVE; INTRAVENOUS ANESTHETIC AGENT; NEUROMUSCULAR DEPOLARIZING AGENT;

ACCELEROMYOGRAPHY; ADULT; ANESTHESIA; ANESTHESIA COMPLICATION; ARTERIAL PRESSURE; ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOSE RESPONSE; DRUG SAFETY; FACIAL EXPRESSION; FEMALE; HEADACHE; HEART ARREST; HICCUP; HUMAN; HYPERTENSION; HYPOTENSION; INJECTION; MALE; MONITORING; MULTICENTER STUDY; MUSCLE WEAKNESS; MYOGRAPHY; NAUSEA; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR SYSTEM; OLIGURIA; PAIN; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SIDE EFFECT; SUCKING; SURGICAL PATIENT; SYSTOLIC BLOOD PRESSURE; TIME; VERTIGO; VOMITING; DRUG ADMINISTRATION; DRUG ANTAGONISM; DRUG TOXICITY; INTRAVENOUS ANESTHESIA; MIDDLE AGED;

ANDROSTANOLS; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INTRAVENOUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG TOXICITY; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR DEPOLARIZING AGENTS; PROPOFOL;

EID: 48849112776     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31817f5bc7     Document Type: Article

References (24)

1. Bom A, Bradley M, Cameron K, Clark JK, Van Egmond J, Feilden H, MacLean EJ, Muir AW, Palin R, Rees DC, Zhang MQ: A novel concept of reversing neuromuscular block: Chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl 2002; 41:266-70
2. Epemolu O, Bom A, Hope F, Mason R: Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969. ANESTHESIOLOGY 2003; 99:632-7
3. Gijsenbergh F, Ramael S, Houwing N, van Iersel T: First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. ANESTHESIOLOGY 2005; 103:695-703
4. McCourt KC, Salmela L, Mirakhur RK, Carroll M, Mäkinen MT, Kansanaho M, Kerr C, Roest GJ, Olkkola KT: Comparison of rocuronium and suxamethonium for use during rapid sequence induction of anaesthesia. Anaesthesia 1998; 53:867-71
5. Heier T, Caldwell JE: Rapid tracheal intubation with large-dose rocuronium: A probability-based approach. Anesth Analg 2000; 90:175-9
6. Andrews JI, Kumar N, van den Brom RH, Olkkola KT, Roest GJ, Wright PM: A large simple randomized trial of rocuronium versus succinylcholine in rapid-sequence induction of anaesthesia along with propofol. Acta Anaesthesiol Scand 1999; 43:4-8
7. Claudius C, Karacan H, Viby-Mogensen J: Prolonged residual paralysis after a single intubating dose of rocuronium. Br J Anaesth 2007; 99:514-7
8. Kopman AF: Sugammadex: A revolutionary approach to neuromuscular antagonism. ANESTHESIOLOGY 2006; 104:631-3
9. Eikermann M, Vogt FM, Herbstreit F, Vahid-Dastgerdi M, Zenge MO, Ochterbeck C, de Greiff A, Peters J: The predisposition to inspiratory upper airway collapse during partial neuromuscular blockade. Am J Respir Crit Care Med 2007; 175:9-15
10. Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J: 8th International Neuromuscular Meeting: Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: The Stockholm revision. Acta Anaesthesiol Scand 2007; 51:789-808
11. Sparr HJ, Vermeyen KM, Beaufort AM, Rietbergen H, Proost JH, Saldien V, Velik-Salchner C, Wierda JM: Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: Efficacy, safety, and pharmacokinetics. ANESTHESIOLOGY 2007; 106:935-43
12. Bainton R, Barnard N, Wiles JR, Brice J: Sinus arrest complicating a bitemporal approach to the treatment of pan-facial fractures. Br J Oral Maxillofac Surg 1990; 28:109-10
13. Groudine SB, Soto R, Lien C, Drover D, Roberts K: A randomized, dose-finding, phase II study of the selective relaxant binding drug, sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth Analg 2007; 104:555-62
14. Sorgenfrei IF, Norrild K, Larsen PB, Stensballe J, Ostergaard D, Prins ME, Viby-Mogensen J: Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: A dose-finding and safety study. ANESTHESIOLOGY 2006; 104:667-74
15. Puhringer FK, Khuenl-Brady KS, Koller J, Mitterschiffthaler G: Evaluation of the endotracheal intubating conditions of rocunonium (ORG 9426) and succinylcholine in outpatient surgery. Anesth Analg 1992; 75:37-40
16. Magorian T, Flannery KB, Miller RD: Comparison of rocuronium, succinylcholine, and vecuronium for rapid-sequence induction of anesthesia in adult patients. ANESTHESIOLOGY 1993; 79:913-8
17. Larsen PB, Hansen EG, Jacobsen LS, Wiis J, Holst P, Rottensten H, Siddiqui R, Wittrup H, Sørensen AM, Persson S, Engbaek J: Intubation conditions after rocuronium or succinylcholine for rapid sequence induction with alfentanil and propofol in the emergency patient. Eur J Anaesthesiol 2005; 22:748-53
18. Perry J, Lee J, Wells G: Rocuronium versus succinylcholine for rapid sequence induction intubation. Cochrane Database Syst Rev 2003; CD002788
19. Kirkegaard-Nielsen H, Caldwell JE, Berry PD: Rapid tracheal intubation with rocuronium: A probability approach to determining dose. ANESTHESIOLOGY 1999; 91:131-6
20. Lee C, Jahr JS, Candiotti K, Warriner B, Zornow MH: Reversal of profound rocuronium NMB with sugammadex is faster than recovery from succinylcholine (abstract). ANESTHESIOLOGY 2007; 107:A988
21. de Kam PJ, van Kuijk J, Smeets J, Thomsen T, Peeters P: Single IV sugammadex doses up to 32 mg/kg are not associated with QT/QTc prolongations (abstract). ANESTHESIOLOGY 2007; 107:A898
22. Hunter JM, Flockton EA: The doughnut and the hole: A new pharmacological concept for anaesthetists. Br J Anaesth 2006; 97:123-6
23. Lanier WL, Iaizzo PA, Milde JH, Sharbrough FW: The cerebral and systemic effects of movement in response to a noxious stimulus in lightly anesthetized dogs: Possible modulation of cerebral function by muscle afferents. ANESTHESIOLOGY 1994; 80:392-401
24. Vasella FC, Frascarolo P, Spahn DR, Magnusson L: Antagonism of neuromuscular blockade but not muscle relaxation affects depth of anaesthesia. Br J Anaesth 2005; 94:742-7